Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.13 USD | +0.62% | +13.67% | +8.04% |
05-02 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
05-02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.04% | 1.74B | |
+73.46% | 12.41B | |
-16.75% | 8.12B | |
+5.93% | 6.59B | |
-5.75% | 5.83B | |
+13.79% | 5.46B | |
+40.99% | 5.05B | |
-19.05% | 4.02B | |
-34.55% | 2.47B | |
-1.11% | 2.02B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Wedbush Cuts NovoCure's Price Target to $53 From $65 After Lower-Than-Expected Q1 Results, Keeps Underperform Rating